Is it appropriate to chew nicotine lozenges 2–3 times before placing them between the gum and cheek in a patient using a 14 mg nicotine patch and 2 mg nicotine mints, who is also taking lisdexamfetamine 60 mg and duloxetine 50 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Chewing Nicotine Lozenges Is Not Recommended

Nicotine lozenges should NOT be chewed 2-3 times before parking—they should be parked between the gum and cheek without chewing and left in place until completely dissolved. 1

Critical Distinction: Lozenges vs. Gum

The 2025 Canadian Cardiovascular Society guidelines make a clear distinction between nicotine gum and lozenges:

Nicotine Gum (Correct "Chew and Park" Method)

  • Chew 2-3 times then park between gum and buccal mucosa for 15-30 minutes 1
  • This allows nicotine absorption and prevents gastrointestinal symptoms
  • The peppery taste indicates proper nicotine release

Nicotine Lozenges (NO Chewing)

  • Should be parked between gum and buccal mucosa without chewing
  • Left in place until it dissolves completely 1
  • Up to 20 lozenges can be consumed per day as needed

Why This Matters

Chewing lozenges contrary to instructions does not lead to faster or higher nicotine absorption 2. Research specifically examining different administration methods of the 4 mg lozenge found that chewing and swallowing (either immediately or after 5 minutes) did not improve pharmacokinetic profiles compared to proper use 2. The lozenge is designed for slow, steady nicotine release through buccal absorption—chewing defeats this purpose.

Your Current Regimen Context

Given your combination therapy (14 mg patch + 2 mg nicotine mints):

  • You're already using combination NRT, which is evidence-based and superior to single-form NRT (RR 1.25,95% CI 1.15-1.36) 1
  • The 14 mg patch provides baseline nicotine coverage
  • The 2 mg lozenges/mints serve as "rescue" therapy for breakthrough cravings
  • Proper lozenge use (parking without chewing) allows optimal nicotine absorption over the intended timeframe

Medication Interaction Considerations

Your concurrent medications (lisdexamfetamine 60 mg and duloxetine 50 mg) do not contraindicate NRT use:

  • Nicotine overdose is rare and smokers typically self-titrate effectively 1
  • Symptoms of nicotine excess include bradycardia, tachycardia, headache, nausea, or weakness 1
  • Neither lisdexamfetamine nor duloxetine have significant pharmacokinetic interactions with nicotine
  • However, be aware that duloxetine can cause tachycardia as an adverse effect 3, which could overlap with nicotine excess symptoms

Common Pitfall to Avoid

The manufacturer's packaging doesn't list chewing because lozenges are NOT meant to be chewed—this is the correct formulation design, not an oversight. The 2-hour dissolution time you're experiencing is the intended pharmacokinetic profile for sustained nicotine delivery 2.

Practical Recommendation

Continue using your 2 mg nicotine lozenges by parking them (without chewing) between your gum and cheek until fully dissolved. If you find the 2+ hour duration inconvenient or if you're experiencing breakthrough cravings:

  • Consider using lozenges more frequently (up to 20 per day is safe) 1
  • Alternatively, discuss switching to nicotine gum (which uses the "chew and park" method) or faster-acting forms like nicotine spray (1 mg per spray) with your provider 1
  • Ensure adequate total nicotine replacement: If you previously smoked 1 pack/day (20+ cigarettes = 20+ mg nicotine), your current 14 mg patch + occasional 2 mg lozenges may be underdosing you, which is a frequent cause of cessation failure 1

References

Research

Pharmacokinetics of a nicotine polacrilex lozenge.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.